Institutional members access full text with Ovid®

Share this article on:

Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes

Spratt, Alexander MD; Blieden, Lauren S. MD; Dubovy, Sander R. MD; Berrocal, Audina MD; Lee, Richard K. MD, PhD

doi: 10.1097/IJG.0000000000000543
Online Articles: Brief Reports

Purpose: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes.

Patients and Methods: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center.

Results: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease.

Conclusions: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL

The Bascom Palmer Eye Institute is supported by an unrestricted research grant from Research to Prevent Blindness and NIH center grant EY014801.

Disclosure: The authors declare no conflict of interest.

Reprints: Richard K. Lee, MD, PhD, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136 (e-mail: rlee@med.miami.edu).

Received July 3, 2016

Accepted August 5, 2016

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.